Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation

G Wolf, S Singh, K Blakolmer, L Lerer, T Lifschytz… - Molecular …, 2023 - nature.com
Schizophrenia is a widespread psychiatric disorder that affects 0.5–1.0% of the world's
population and induces significant, long-term disability that exacts high personal and …

Biological subty** of psychiatric syndromes as a pathway for advances in drug discovery and personalized medicine

W Zhang, JA Sweeney, JR Bishop, Q Gong… - Nature Mental …, 2023 - nature.com
Every common psychiatric syndrome is genetically, neurobiologically and clinically
heterogeneous. This heterogeneity may reflect the dimensional variability of a single illness …

Brain heterogeneity in schizophrenia and its association with polygenic risk

D Alnæs, T Kaufmann, D Van Der Meer… - JAMA …, 2019 - jamanetwork.com
Importance Between-individual variability in brain structure is determined by gene-
environment interactions, possibly reflecting differential sensitivity to environmental and …

[HTML][HTML] Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through meta …

TGM Van Erp, E Walton, DP Hibar, L Schmaal… - Biological …, 2018 - Elsevier
Background The profile of cortical neuroanatomical abnormalities in schizophrenia is not
fully understood, despite hundreds of published structural brain imaging studies. This study …

Using country-level variables to classify countries according to the number of confirmed COVID-19 cases: An unsupervised machine learning approach

RM Carrillo-Larco, M Castillo-Cara - Wellcome open research, 2020 - pmc.ncbi.nlm.nih.gov
Background: The COVID-19 pandemic has attracted the attention of researchers and
clinicians whom have provided evidence about risk factors and clinical outcomes. Research …

Neuroimaging biomarkers define neurophysiological subtypes with distinct trajectories in schizophrenia

Y Jiang, J Wang, E Zhou, L Palaniyappan, C Luo… - Nature Mental …, 2023 - nature.com
Technical developments and improved access to neuroimaging techniques have brought us
closer to understanding the neuropathological origins of schizophrenia. Using data-driven …

Psychosis brain subtypes validated in first-episode cohorts and related to illness remission: results from the PHENOM consortium

DB Dwyer, GB Chand, A Pigoni, A Khuntia, J Wen… - Molecular …, 2023 - nature.com
Using machine learning, we recently decomposed the neuroanatomical heterogeneity of
established schizophrenia to discover two volumetric subgroups—a 'lower brain …

Multi-scale semi-supervised clustering of brain images: Deriving disease subtypes

J Wen, E Varol, A Sotiras, Z Yang, GB Chand… - Medical image …, 2022 - Elsevier
Disease heterogeneity is a significant obstacle to understanding pathological processes and
delivering precision diagnostics and treatment. Clustering methods have gained popularity …

[HTML][HTML] Structural abnormality in schizophrenia versus bipolar disorder: a whole brain cortical thickness, surface area, volume and gyrification analyses

M Madre, EJ Canales-Rodríguez… - NeuroImage: Clinical, 2020 - Elsevier
Objectives The profiles of cortical abnormalities in schizophrenia and bipolar disorder, and
how far they resemble each other, have only been studied to a limited extent. The aim of this …

Morphological profiling of schizophrenia: cluster analysis of MRI-based cortical thickness data

Y Pan, W Pu, X Chen, X Huang, Y Cai… - Schizophrenia …, 2020 - academic.oup.com
The diagnosis of schizophrenia is thought to embrace several distinct subgroups. The
manifold entities in a single clinical patient group increase the variance of biological …